 Cristina Penaranda
Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Host-Pathogen Interactions | 4 | 2021 | 364 | 1.250 |
Why?
| | Pseudomonas aeruginosa | 3 | 2021 | 352 | 0.840 |
Why?
| | Bacterial Infections | 2 | 2019 | 250 | 0.550 |
Why?
| | Adaptation, Physiological | 1 | 2021 | 553 | 0.530 |
Why?
| | T-Lymphocytes, Regulatory | 4 | 2011 | 388 | 0.480 |
Why?
| | Islets of Langerhans | 3 | 2010 | 803 | 0.460 |
Why?
| | Immune Tolerance | 3 | 2012 | 363 | 0.400 |
Why?
| | Immunologic Memory | 2 | 2012 | 353 | 0.390 |
Why?
| | Receptors, Interleukin-7 | 1 | 2012 | 28 | 0.390 |
Why?
| | Bacteria | 1 | 2019 | 858 | 0.380 |
Why?
| | Interleukin-7 | 1 | 2012 | 61 | 0.380 |
Why?
| | Diabetes Mellitus, Type 1 | 5 | 2012 | 3717 | 0.370 |
Why?
| | CD3 Complex | 1 | 2011 | 106 | 0.350 |
Why?
| | Lymphocyte Depletion | 1 | 2011 | 135 | 0.350 |
Why?
| | T-Lymphocyte Subsets | 2 | 2011 | 417 | 0.340 |
Why?
| | Propylene Glycols | 1 | 2010 | 28 | 0.330 |
Why?
| | Sphingosine | 1 | 2010 | 46 | 0.320 |
Why?
| | T-Lymphocytes | 4 | 2014 | 1998 | 0.300 |
Why?
| | Pseudomonas Infections | 2 | 2021 | 225 | 0.290 |
Why?
| | Mice, Inbred NOD | 5 | 2012 | 601 | 0.260 |
Why?
| | Autoimmunity | 2 | 2009 | 908 | 0.250 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2009 | 719 | 0.250 |
Why?
| | Immunosuppressive Agents | 1 | 2010 | 894 | 0.230 |
Why?
| | Antibodies, Monoclonal | 1 | 2011 | 1430 | 0.220 |
Why?
| | Mice | 13 | 2021 | 17794 | 0.210 |
Why?
| | Gene Expression Profiling | 2 | 2021 | 1775 | 0.200 |
Why?
| | Animals | 18 | 2021 | 36951 | 0.200 |
Why?
| | Receptor, IGF Type 1 | 3 | 2007 | 65 | 0.190 |
Why?
| | Signal Transduction | 3 | 2012 | 5081 | 0.180 |
Why?
| | Diabetes Mellitus | 1 | 2010 | 1041 | 0.180 |
Why?
| | Intracellular Space | 1 | 2021 | 68 | 0.170 |
Why?
| | Microbial Viability | 1 | 2021 | 91 | 0.170 |
Why?
| | Genetic Fitness | 1 | 2021 | 59 | 0.170 |
Why?
| | Interferon-gamma | 4 | 2014 | 789 | 0.150 |
Why?
| | Chimera | 1 | 2018 | 58 | 0.150 |
Why?
| | Urinary Tract Infections | 1 | 2021 | 188 | 0.150 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2021 | 328 | 0.150 |
Why?
| | RNA, Bacterial | 1 | 2019 | 190 | 0.150 |
Why?
| | Host-Parasite Interactions | 1 | 2019 | 114 | 0.150 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2019 | 61 | 0.140 |
Why?
| | Embryo, Nonmammalian | 1 | 2018 | 167 | 0.140 |
Why?
| | Genome, Bacterial | 1 | 2019 | 142 | 0.140 |
Why?
| | Embryo, Mammalian | 1 | 2018 | 232 | 0.140 |
Why?
| | Hematopoiesis | 1 | 2018 | 192 | 0.140 |
Why?
| | Mice, Transgenic | 4 | 2011 | 2167 | 0.130 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5764 | 0.130 |
Why?
| | Masoprocol | 2 | 2007 | 3 | 0.130 |
Why?
| | Tuberculosis | 1 | 2019 | 279 | 0.130 |
Why?
| | Mycobacterium tuberculosis | 1 | 2019 | 314 | 0.130 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 452 | 0.120 |
Why?
| | Urea | 2 | 2006 | 81 | 0.120 |
Why?
| | Lymphocyte Activation | 3 | 2012 | 1142 | 0.120 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 313 | 0.120 |
Why?
| | Cells, Cultured | 2 | 2021 | 4193 | 0.120 |
Why?
| | Adoptive Transfer | 2 | 2012 | 221 | 0.110 |
Why?
| | Zebrafish | 1 | 2018 | 499 | 0.110 |
Why?
| | Salmonella typhimurium | 1 | 2015 | 183 | 0.110 |
Why?
| | Bacteroides fragilis | 1 | 2013 | 13 | 0.100 |
Why?
| | Galactosylceramides | 1 | 2013 | 25 | 0.100 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2012 | 249 | 0.100 |
Why?
| | DNA-Binding Proteins | 2 | 2011 | 1502 | 0.100 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2010 | 1091 | 0.100 |
Why?
| | Transcriptome | 1 | 2019 | 972 | 0.100 |
Why?
| | Regeneration | 1 | 2014 | 197 | 0.100 |
Why?
| | Antigens, Differentiation | 1 | 2012 | 83 | 0.100 |
Why?
| | Pancreas | 1 | 2014 | 329 | 0.090 |
Why?
| | Macrophages | 3 | 2015 | 1549 | 0.090 |
Why?
| | RNA, Messenger | 1 | 2019 | 2834 | 0.090 |
Why?
| | Mice, Inbred BALB C | 2 | 2011 | 1272 | 0.080 |
Why?
| | Thymus Gland | 1 | 2011 | 312 | 0.080 |
Why?
| | Interleukin-2 | 2 | 2009 | 455 | 0.080 |
Why?
| | Autoimmune Diseases | 2 | 2011 | 460 | 0.080 |
Why?
| | Fingolimod Hydrochloride | 1 | 2010 | 40 | 0.080 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2011 | 195 | 0.080 |
Why?
| | Transcription Factors | 2 | 2011 | 1719 | 0.080 |
Why?
| | Forkhead Transcription Factors | 1 | 2009 | 191 | 0.070 |
Why?
| | Immunity, Innate | 1 | 2014 | 828 | 0.070 |
Why?
| | Lymphocytes | 1 | 2010 | 397 | 0.070 |
Why?
| | Lipoxygenase Inhibitors | 1 | 2007 | 37 | 0.070 |
Why?
| | Graft Rejection | 1 | 2011 | 624 | 0.070 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2006 | 18 | 0.060 |
Why?
| | Autoantigens | 1 | 2009 | 430 | 0.060 |
Why?
| | Aminoquinolines | 1 | 2006 | 19 | 0.060 |
Why?
| | Immunotherapy | 1 | 2011 | 641 | 0.060 |
Why?
| | Cell Line | 1 | 2011 | 2847 | 0.060 |
Why?
| | Phenylurea Compounds | 1 | 2006 | 97 | 0.060 |
Why?
| | Breast Neoplasms | 3 | 2007 | 2253 | 0.060 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2005 | 319 | 0.050 |
Why?
| | Receptor, ErbB-2 | 1 | 2005 | 341 | 0.050 |
Why?
| | Mice, Knockout | 1 | 2010 | 3018 | 0.050 |
Why?
| | Female | 5 | 2021 | 73465 | 0.050 |
Why?
| | Humans | 8 | 2019 | 137782 | 0.040 |
Why?
| | Protein Kinase Inhibitors | 1 | 2006 | 916 | 0.040 |
Why?
| | Apoptosis | 2 | 2006 | 2553 | 0.040 |
Why?
| | Dendritic Cells | 1 | 2003 | 483 | 0.040 |
Why?
| | Nucleic Acid Hybridization | 1 | 2019 | 190 | 0.040 |
Why?
| | Genes, Essential | 1 | 2019 | 23 | 0.040 |
Why?
| | Blastula | 1 | 2018 | 3 | 0.040 |
Why?
| | Cell Fusion | 1 | 2018 | 51 | 0.040 |
Why?
| | Cell Tracking | 1 | 2018 | 17 | 0.040 |
Why?
| | Coloring Agents | 1 | 2018 | 87 | 0.040 |
Why?
| | DNA Transposable Elements | 1 | 2019 | 121 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 194 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2005 | 2475 | 0.040 |
Why?
| | Larva | 1 | 2018 | 226 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2018 | 316 | 0.030 |
Why?
| | Myeloid Cells | 1 | 2018 | 148 | 0.030 |
Why?
| | Bone Marrow Transplantation | 1 | 2018 | 286 | 0.030 |
Why?
| | Cell Lineage | 1 | 2018 | 350 | 0.030 |
Why?
| | Neoplasms | 1 | 2011 | 2673 | 0.030 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2015 | 60 | 0.030 |
Why?
| | Salmonella Infections | 1 | 2015 | 57 | 0.030 |
Why?
| | Models, Statistical | 1 | 2019 | 669 | 0.030 |
Why?
| | Ceruletide | 1 | 2014 | 4 | 0.030 |
Why?
| | Acinar Cells | 1 | 2014 | 13 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2006 | 2129 | 0.030 |
Why?
| | Interferon Type I | 1 | 2015 | 140 | 0.030 |
Why?
| | Cell Dedifferentiation | 1 | 2014 | 32 | 0.030 |
Why?
| | Cell Line, Tumor | 3 | 2007 | 3415 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 967 | 0.030 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2014 | 173 | 0.030 |
Why?
| | Young Adult | 1 | 2010 | 13240 | 0.030 |
Why?
| | Macrophage Activation | 1 | 2014 | 201 | 0.030 |
Why?
| | Natural Killer T-Cells | 1 | 2013 | 67 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2015 | 886 | 0.020 |
Why?
| | Receptor Cross-Talk | 1 | 2011 | 21 | 0.020 |
Why?
| | CD28 Antigens | 1 | 2011 | 53 | 0.020 |
Why?
| | B7-1 Antigen | 1 | 2011 | 58 | 0.020 |
Why?
| | Antigen-Presenting Cells | 1 | 2011 | 156 | 0.020 |
Why?
| | CTLA-4 Antigen | 1 | 2011 | 99 | 0.020 |
Why?
| | Adolescent | 1 | 2010 | 21574 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2014 | 506 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2011 | 188 | 0.020 |
Why?
| | Child | 1 | 2010 | 21989 | 0.020 |
Why?
| | Complementarity Determining Regions | 1 | 2009 | 51 | 0.020 |
Why?
| | CpG Islands | 1 | 2009 | 157 | 0.020 |
Why?
| | B-Lymphocytes | 1 | 2014 | 847 | 0.020 |
Why?
| | Interleukin-17 | 1 | 2009 | 119 | 0.020 |
Why?
| | Neutrophils | 1 | 2014 | 1238 | 0.020 |
Why?
| | Luminescent Proteins | 1 | 2009 | 179 | 0.020 |
Why?
| | Antigens, CD | 1 | 2011 | 521 | 0.020 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2008 | 81 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2009 | 318 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 233 | 0.020 |
Why?
| | Cricetulus | 1 | 2006 | 109 | 0.020 |
Why?
| | CHO Cells | 1 | 2006 | 161 | 0.020 |
Why?
| | Cricetinae | 1 | 2006 | 289 | 0.020 |
Why?
| | Hematopoietic Stem Cells | 1 | 2009 | 406 | 0.020 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 2006 | 68 | 0.020 |
Why?
| | Lymph Nodes | 1 | 2008 | 491 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2009 | 2139 | 0.010 |
Why?
| | Animals, Genetically Modified | 1 | 2006 | 240 | 0.010 |
Why?
| | Caspases | 1 | 2006 | 247 | 0.010 |
Why?
| | Neoplasms, Experimental | 1 | 2005 | 176 | 0.010 |
Why?
| | Cell Survival | 1 | 2008 | 1120 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2900 | 0.010 |
Why?
| | Cell Division | 1 | 2006 | 794 | 0.010 |
Why?
| | DNA Methylation | 1 | 2009 | 643 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 2003 | 137 | 0.010 |
Why?
| | 3T3 Cells | 1 | 2003 | 163 | 0.010 |
Why?
| | Inflammation | 1 | 2014 | 2838 | 0.010 |
Why?
| | T-Box Domain Proteins | 1 | 2003 | 98 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2005 | 1316 | 0.010 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2003 | 152 | 0.010 |
Why?
| | Mutation | 1 | 2013 | 3959 | 0.010 |
Why?
| | Antigens | 1 | 2003 | 357 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 976 | 0.010 |
Why?
| | Phosphorylation | 1 | 2005 | 1759 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 853 | 0.010 |
Why?
| | Blotting, Western | 1 | 2003 | 1227 | 0.010 |
Why?
| | Up-Regulation | 1 | 2003 | 843 | 0.010 |
Why?
| | Time Factors | 1 | 2003 | 6834 | 0.010 |
Why?
| | Male | 1 | 2018 | 67906 | 0.010 |
Why?
|
|
Penaranda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|